Vimarsana
Biggest News Aggregation in the World

Sciences Fund News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sciences Fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sciences Fund Today - Breaking & Trending Today

CNBC Power Lunch October 21, 2015 - Vimarsana News

CNBC Power Lunch October 21, 2015

First day. Different story for valeant. The pharma giant taking it on the chin on a report by a short seller. Western digital buying sandisk. The tech stocks that could be next on the chopping block for the next to be acquired. And scott wapner just talked with carl icahn. Hes taking his activism to a whole new level and realm targeting Corporate Tax reform. But we begin with the red hot ipo of the day, shares of ferrari are revving higher on their first day of trading. A bit of a rally in stocks overall. Were sitting at 12,290 but just earlier today we cracked above that 17,300 mark for First...

CSPAN Question Time January 12, 2015 - Vimarsana News

CSPAN Question Time January 12, 2015

Interviews are available online. Here are some others you might like. Scott berg on woodrow wilson. And amity shlaes on calvin coolidge. Www. Cspan. Org you can watch them atwww. Cspan. Org. Here are a few of the comments we have recently received on the 114th congress. The thing that really needs to happen is going back to what the incoming majority said, they need to get back to regular order. If they go back impact of 13 bills it would take to fund the government, everybody can see who voted for it. To put what amendment up, and let the president passed it or veto it. I hope it is a more ma...

Institution Asks Court to Allow Renaming of Sackler Funding - Vimarsana News

Institution Asks Court to Allow Renaming of Sackler Funding

Institution Asks Court to Allow Renaming of Sackler Funding

Source: 997wtn.com
AbilityPharma closes €7 million round for metastatic pancreatic cancer drug ABTL0812 - Vimarsana News

AbilityPharma closes €7 million round for metastatic pancreatic cancer drug ABTL0812

AbilityPharma closes €7 million round to fully fund its international Phase 2b clinical trial with the antitumor drug ABTL0812 in pancreatic cancer patients. 

Source: asebio.com
AbilityPharma Raises €7M in Financing - Vimarsana News

AbilityPharma Raises €7M in Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!